PTC Therapeutics Inc Cash Flow Quality Index
PTC Therapeutics Inc cash flow quality index. PTC Therapeutics Inc (PTCT) has a Cash Flow Quality Index of -4.17x as of September 2025. Operating cash flow of $-66.30 Million is below net income of $15.90 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow to debt ratio of PTC Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of PTC Therapeutics Inc (2011–2025)
Cash flow quality index of PTC Therapeutics Inc from 2011 to 2025. Historical Cash Flow Quality Index for PTC Therapeutics Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. See PTC Therapeutics Inc balance sheet independence to measure how much of total assets are equity-financed.
PTC Therapeutics Inc Cash Flow Quality Index by Year (2011–2025)
PTC Therapeutics Inc cash flow quality index by year from 2011 to 2025. Year-by-year earnings quality comparison for PTC Therapeutics Inc. For the full cash flow conversion analysis, see PTC Therapeutics Inc (PTCT) cash conversion ratio.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.04x | $711.20 Million | $682.64 Million | ▲ +255.0% |
| 2011 | -0.67x | $-20.77 Million | $30.90 Million | — |